Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
Recent
price
P/E
ratio
div
yld
53.63%
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.